BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29927501)

  • 1. Children with MEN1 gene mutations may present first (and at a young age) with Cushing disease.
    Makri A; Bonella MB; Keil MF; Hernandez-Ramirez L; Paluch G; Tirosh A; Saldarriaga C; Chittiboina P; Marx SJ; Stratakis CA; Lodish M
    Clin Endocrinol (Oxf); 2018 Oct; 89(4):437-443. PubMed ID: 29927501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation.
    Alzahrani AS; Al-Khaldi N; Shi Y; Al-Rijjal RA; Zou M; Baitei EY; Amin T
    Endocr Pract; 2008; 14(5):595-602. PubMed ID: 18753104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's syndrome in multiple endocrine neoplasia type 1.
    Simonds WF; Varghese S; Marx SJ; Nieman LK
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):379-86. PubMed ID: 21916912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1.
    Rix M; Hertel NT; Nielsen FC; Jacobsen BB; Hoejberg AS; Brixen K; Hangaard J; Kroustrup JP
    Eur J Endocrinol; 2004 Dec; 151(6):709-15. PubMed ID: 15588237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.
    Park JH; Kim IJ; Kang HC; Lee SH; Shin Y; Kim KH; Lim SB; Kang SB; Lee K; Kim SY; Lee MS; Lee MK; Park JH; Moon SD; Park JG
    Clin Genet; 2003 Jul; 64(1):48-53. PubMed ID: 12791038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.
    Stratakis CA; Tichomirowa MA; Boikos S; Azevedo MF; Lodish M; Martari M; Verma S; Daly AF; Raygada M; Keil MF; Papademetriou J; Drori-Herishanu L; Horvath A; Tsang KM; Nesterova M; Franklin S; Vanbellinghen JF; Bours V; Salvatori R; Beckers A
    Clin Genet; 2010 Nov; 78(5):457-63. PubMed ID: 20507346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing.
    Cardinal JW; Bergman L; Hayward N; Sweet A; Warner J; Marks L; Learoyd D; Dwight T; Robinson B; Epstein M; Smith M; Teh BT; Cameron DP; Prins JB
    J Med Genet; 2005 Jan; 42(1):69-74. PubMed ID: 15635078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
    Agarwal SK; Kester MB; Debelenko LV; Heppner C; Emmert-Buck MR; Skarulis MC; Doppman JL; Kim YS; Lubensky IA; Zhuang Z; Green JS; Guru SC; Manickam P; Olufemi SE; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Hum Mol Genet; 1997 Jul; 6(7):1169-75. PubMed ID: 9215689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
    Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
    Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
    Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
    Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
    Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation.
    Hasani-Ranjbar S; Rahmanian M; Ebrahim-Habibi A; Soltani A; Soltanzade A; Mahrampour E; Amoli MM
    Fam Cancer; 2014 Jun; 13(2):267-72. PubMed ID: 24218143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
    Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
    Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Cushing's syndrome.
    Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
    Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.